Scopus BioPharma Inc. announced that stockholders of the Company have elected Dr. Laster's two director nominees, Mordechai Saar Hacham and Joshua Levine to the company's Board of Directors at the Company's 2021 Annual Meeting of Stockholders. The company also appointed the Company's director nominees, Raphael (Rafi) Hofstein and David S. Battleman as directors.